{
    "2019-01-04": [
        [
            {
                "time": "2018-09-14",
                "original_text": "Tilray Gains More Than 200%: Is There More Scope for Growth?",
                "features": {
                    "keywords": [
                        "Tilray",
                        "Gains",
                        "200%"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-14",
                "original_text": "These Stocks Pop After FDA Expedites Review Of Gene-Editing Therapy",
                "features": {
                    "keywords": [
                        "Stocks",
                        "FDA",
                        "Expedites",
                        "Gene-Editing",
                        "Therapy"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}